All Posts

If this is your first time using injectable medications like GLP-1s, it's tempting to toss the needle or pen in the trash after use. Don’t. Knowing how to safely dispose of needles after your weekly dose is vital for safety and legality.

If you’ve started taking Ozempic, Wegovy, Zepbound, or Mounjaro and suddenly feel like you can’t warm up, welcome to the club. Feeling...

Looking for healthy Zepbound-friendly snacks you can stash in your bag, car, or desk drawer? Users on Zepbound (tirzepatide) often...

If you’re riding the GLP-1 wave and wondering why your stomach feels like a balloon animal, you’re not alone. Bloating is one of the most common complaints—and luckily, it’s one you can do something about. The key to stopping bloating is breaking some old habits and introducing some new solutions as your gut bacteria work to adapt.

If you’ve just started a GLP-1 medication or are getting ready to start, you need to prepare for a loss of appetite. At the same time, proper nutrition is more important than ever. Protein is a critical source to preserve muscles and keep fat burning instead of muscles. This is when the best protein shakes can seriously help.

How GLP-1 Receptor Agonists Affect Contraceptive Effectiveness—and What to Do About It If you’re on or considering a GLP-1 medication...

If you're thinking about starting a GLP-1 medication for obesity, like Wegovy or Zepbound, you’ve probably started researching what has...

If you've ever felt judged at the doctor's office, this is the update you've been waiting for. How healthcare professionals talk about...

This question comes from one of the GLP-1 Newsroom readers. She wants to start back up on Ozempic after she gives birth, but can she take Ozempic while breastfeeding? I decided to do some digging and get all the information in one place to help other moms-to-be looking to rejoin their health program as soon as it is safe for momma and baby.

Maybe you’ve heard of Ozempic or Zepbound in passing—on the news, in a group chat, or from a coworker who “just isn’t hungry anymore.”...

You’ve probably heard the term metabolic syndrome tossed around lately—on wellness podcasts, in doctors’ offices, even on TikTok. It sounds serious (it is), but also vague (it kind of is). Is it diabetes? A slow metabolism? Is it just another name for being overweight? Not exactly. In this article, we'll explore what metabolic syndrome is, its risk factors

You can't turn a corner or scroll a social media site without seeing an ad or a post about someone taking GLP-1 meds like Ozempic or Wegovy. Most research shows one in eight people have tried them or is currently on them. Now, a new GLP-1 map shows a state-by-state breakdown of how many people are using these medications.

The way people eat is changing—and it’s not just another wellness trend. GLP-1 medications like Ozempic and Zepbound are rewriting the...

First, it was “Ozempic face”—that gaunt, hollowed look some people noticed after rapid weight loss on semaglutide. Then came the neck,...

In a major shake-up that’s bound to impact millions of patients, CVS Caremark is cutting ties with Eli Lilly’s weight loss drug Zepbound—and making Novo Nordisk’s Wegovy the go-to GLP-1 for obesity treatment. If your insurance runs through CVS Caremark, here’s what’s changing, why it’s happening, and what you should do next.

It turns out, sleep apnea is one of the many benefits science is exploring for GLP-1 agonists. While Zepbound got the first nod for OSA, there's a world of sleep standing between you and taking GLP-1s.

The landscape of diabetes and obesity management is on the cusp of a significant transformation, driven by the development of oral...

The World Health Organization (WHO) is getting ready to make a move that could reshape how the world handles obesity. For the first time,...

With demand for GLP-1 medications like semaglutide and tirzepatide soaring, clinical trials have quietly become one of the only ways some people can access treatment, especially if they’re uninsured or can’t afford retail prices. But before you go signing up for an experimental dose of the next Ozempic or peptide agonist, there are a few important things to understand. In this article, we'll talk about what clinical trials are, their pros and cons, what to expect, and how to

Retatrutide is being called the “triple threat” of weight loss drugs—and it’s not even on the market yet. Developed by Eli Lilly, the same pharmaceutical giant behind tirzepatide (better known as Mounjaro and Zepbound), this new contender is generating buzz for its potential to help people lose more weight, faster.